RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com



new TOP 200 Companies filing patents this week

new Companies with the Most Patent Filings (2010+)




RealTimeTouch.com RealTimeTouch.com Patent US9639150 RealTimeTouch.com message RealTimeTouch.com RealTimeTouch.com

Similar
Filing Names

Mitsubishi Tanabe Pharma Corporation
Mitsubishi Tanabe Pharma Corporation_20100107
  

Mitsubishi Tanabe Pharma Corporation patents

Recent patent applications related to Mitsubishi Tanabe Pharma Corporation. Mitsubishi Tanabe Pharma Corporation is listed as an Agent/Assignee. Note: Mitsubishi Tanabe Pharma Corporation may have other listings under different names/spellings. We're not affiliated with Mitsubishi Tanabe Pharma Corporation, we're just tracking patents.

ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009 | Company Directory "M" | Mitsubishi Tanabe Pharma Corporation-related inventors




Date Mitsubishi Tanabe Pharma Corporation patents (updated weekly) - BOOKMARK this page
03/23/17Antibody-fynomer conjugates
02/23/17Aromatic heterocyclic compound
02/16/17Novel disubstituted 1, 2, 4-triazine compound
02/16/17Novel 2-amino-pyridine and 2-amino-pyrimidine derivatives and medicinal use thereof
01/19/17Medicament for suppressing malignant tumor metastasis
12/29/16Novel bicyclic or tricyclic heterocyclic compound
12/15/16Method for producing 1,4-benzoxazine compound
10/06/16Human anti-il-33 neutralizing monoclonal antibody
09/22/16Continuous arycyclic compound
08/25/16T cell activation inhibitor, pharmaceutical composition containing same, and screening t cell activation inhibiting substance
08/11/16Tablets containing a 1-(ß-d-glucopyranosyl)-3-(phenylthienylmethyl)benzene compound
07/14/16Novel crystalline arylalkylamine compound and process for producing the same
07/07/16Therapeutic agent for ophthalmic disease
05/26/16Nitrogen-containing saturated heterocyclic compound
04/21/16Glucopyranoside compound
01/07/16Method for producing a-halo-tetraacyl-glucose
11/26/15Antitumor agent
08/27/15Pyrazolopyrimidine compound
08/20/15Novel renin inhibitor
08/06/15Rotavirus-like particle production in plants
08/06/15Method for producing 1,4-benzoxazine compound
08/06/15Sulfonamide compounds having trpm8 antagonistic activity
07/02/15Pharmaceutical formulations comprising paraoxonase
06/11/15Aromatic heterocyclic compound
06/04/15Method for producing optically active naphthalene compound
04/16/15Therapeutic agent for cerebral infarction
04/16/15Therapeutic agent for cerebral infarction
03/26/15Amine compound and use thereof for medical purposes
03/05/15Amidopyridine derivative and use thereof
02/12/15Compositions controlling ph range of release and/or release rate
12/18/14Combination therapy comprising sglt inhibitors and dpp4 inhibitors
11/27/14Therapeutic agent for cerebral infarction
11/27/14Therapeutic agent for cerebral infarction
08/14/14Pharmaceutical agent for treating amyotrophic lateral sclerosis or suppressing disease progress thereof
07/10/14Novel antiplatelet agent
05/01/14Novel pharmaceutical composition
03/20/14Arylalkylamine compound and process for preparing the same
03/13/14Orally disintegrating tablet
01/16/14Ointment with excellent formulation stability
01/09/14Nitrogen-containing saturated heterocyclic compound
10/31/13Polynucleotide construct capable of displaying fab in a cell-free translation system, and manufacturing and screening fab using same
10/03/13Continuous arycyclic compound
09/12/13Optically active cyclic alcohol compound and preparing the same
08/15/13Amide derivative and use thereof
06/13/13Arylalkylamine compound and process for preparing the same
02/28/13Tablets containing a 1-(beta-d-glucopyranosyl)-3-(phenylthienylmethyl)benzene compound
02/14/13Novel amide derivative and use thereof as medicine
02/07/13Tablet
12/27/12T cell activation inhibitor, pharmaceutical composition containing same, and screening t cell activation inhibiting substance
11/01/12Elution-stabilized preparation
10/25/12Plastic container comprising cyclic polyolefin layer
10/04/126-pyrimidinyl-pyrimid-4-one derivative
09/13/12Process for production of biphenyl derivative
08/30/12Pyrimidone compounds
08/30/12The enantiomer of tenatoprazole and the use thereof in therapy
08/16/12Pyrimidone derivatives
08/02/12Therapeutic agent for cerebral infarction
05/31/12Adsorption test spherical carbon adsorbent
05/24/12Novel thyroid hormone beta receptor agonist
04/19/123-[1,4]oxazepane-4-pyrimidone derivatives
03/15/12Novel cell penetrating peptide
11/17/11Salt of proline derivative, solvate thereof, and production method thereof
10/27/11Novel amide derivative and use thereof as medicine
10/20/11Intermediate compound for synthesizing pharmaceutical agent and production method thereof
10/13/11Intermediate compound for synthesizing pharmaceutical agent and production method thereof
Patent Packs
09/15/11Substituted tricyclic derivatives
08/11/11Optically active cyclic alcohol compound and preparing the same
06/16/11Substituted alkyl pyrimidin-4-one derivatives
06/16/11Substituted triazinone derivatives
06/16/11Substituted pyrimidin-4-one derivatives
06/16/11Substituted pyrimidone derivatives
06/16/11Substituted pyrimido isoquinoline derivatives
06/09/11Substituted n-oxide pyrazine derivatives
06/02/11Novel salt of isoquinoline compound and crystal thereof
03/24/11Plastic container comprising cyclic polyolefin layer
02/17/11Substituted arylamide diazepinopyrimidone derivatives
02/10/11Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers
02/10/11Homocysteine synthase inhibitor
01/20/11Substituted heteroarylamide oxazepinopyrimidone derivatives
01/20/11Substituted arylamide oxazepinopyrimidone derivatives
Patent Packs
01/20/11Substituted heteroarylamide diazepinopyrimidone derivatives
12/23/10Plastic container comprising cyclic polyolefin layer
12/02/10Method of treating abnormal lipid metabolism
12/02/10Crystalline form of piperidine compound
11/11/10Antitumor agent
09/09/10Antibody recognizing antigen
09/09/10Novel malonic acid sulfonamide derivative and pharmaceutical use thereof
07/22/10Method for isolation of cell, serum-free culture medium for cell, and culture of cell
07/15/10Therapeutic agent for cerebral infarction
06/17/10Novel nitrogen-containing heterocyclic compound
04/08/10Heteroarylamide pyrimidone compounds
04/08/10Arylamide pyrimidone derivatives
04/08/10Arylamide pyrimidone compounds
04/01/10Heteroarylamide pyrimidone derivatives
03/11/10Condensed tetrahydroquinoline derivative and use thereof for medical purposes
02/25/10Novel cell penetrating peptide
02/18/10Thienotriazolodiazepine compound and medicinal use thereof
01/07/10Salt or solvate of 5-methyl-2(piperazin-1-yl)benzenesulfonic acid
12/31/09Novel phosphodiesterase and gene thereof
12/10/09Substituted heteroaryl pyridopyrimidone derivatives
11/26/09Process for preparing tetrahydroquinoline derivatives
11/12/09Thiomorpholine compound and process for preparing the same
11/12/09Substituted 8-piperidinyl-2-pyridinyl-pyrimido[1,2-a] pyrimidin-6-one and 8-piperidinyl-2-pyrimidinyl-pyrimido[1,2-a] pyrimidin-6-one derivatives
07/16/09Alicyclic heterocyclic compound
05/28/09Amine compound and use thereof for medical purposes
04/30/09Prophylactic and/or therapeutic drug for nonalcoholic steatohepatitis
04/02/09Prophylactic/therapeutic agent for abnormalities of sugar/lipid metabolism
04/02/094-acylaminopyridine derivative mediated neurogenesis
03/26/09Concomitant pharmaceutical agents and use thereof
03/26/092-aminobutanol compound and use thereof for medical purposes
Social Network Patent Pack
03/19/09Isoquinoline compound and pharmaceutical use thereof
02/05/09Substituted bicyclic pyrimidone derivatives
01/07/10Salt or solvate of 5-methyl-2(piperazin-1-yl)benzenesulfonic acid







ARCHIVE: New 2017 2016 2015 2014 2013 2012 2011 2010 2009



###

This listing is an abstract for educational and research purposes is only meant as a recent sample of applications filed, not a comprehensive history. Freshpatents.com is not affiliated or associated with Mitsubishi Tanabe Pharma Corporation in any way and there may be associated servicemarks. This data is also published to the public by the USPTO and available for free on their website. Note that there may be alternative spellings for Mitsubishi Tanabe Pharma Corporation with additional patents listed. Browse our Agent directory for other possible listings. Page by FreshPatents.com

###




';